Chronic Wound Healing

Wounds, particularly chronic wounds, have been identified as a significant health, social and economic burden. Over 450,000 Australians annually live with a chronic wound, the estimated cost of which is over $2.5B and growing.

Our ageing population, the increasing incidence of diabetes, cardiovascular and renal diseases, road trauma, general increase in surgical procedures and dermatological conditions such as scabies, also impacts significantly on the number and type of wounds in our rural, remote and metropolitan communities across Australia.


Surgical Wound

WMCS can be used in surgical wounds to promote:

  • Haemostasis
  • Pain control
  • Improved collagen synthesis leading to improved cosmetic outcome
  • Accelerated wound healing
  • Reduced keloid scar formation
  • Improved graft recipient site healing and graft uptake

WMCS treatment to reduce post-surgery Keloid formation.

Female patient with scald injury and predisposition for Keloid formation. Both thighs were donor sites for skin graft.

Post donor sites surgery, WMCS treatment of right thigh only in order to evaluate WMCS efficiency in reduction of Keloid formation.

Comparison of donor sites post epithelization:

Right thigh treated with WMCS (one session only) following skin graft surgery.

Left thigh (no WMCS treatment) shows significant keloid development after healing.

Call Us Now

Book an appoinment

(08) 9457 9044 Book Online